as on November 3, 2025 at 11:42 pm IST
Day's Low
Day's High
0.42%
Downside
0.85%
Upside
52 Week's Low
52 Week's High
24.94%
Downside
3.76%
Upside
Check Johnson & Johnson market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$455.0B
EPS (TTM)
10.8643
Dividend Yield
2.93%
Quarterly Earnings Growth YOY
0.91%
PE Ratio (TTM)
18.25
Industry PE ratio
18.176666666666666
PEG Ratio
1.0724
EBITDA
31.9B
Revenue (TTM)
92.1B
Profit Margin
27.26%
Return On Equity TTM
33.62%
Track how Johnson & Johnson P/E has moved over time to understand its valuation trends.
Johnson & Johnson in the last 5 years
Lowest (14.19x)
June 30, 2024
Industry (18.18x)
November 3, 2025
Today (18.25x)
November 3, 2025
Highest (19.45x)
March 31, 2021
Today’s Price to Earnings Ratio: 18.25x
Compare market cap, revenue, PE, and other key metrics of Johnson & Johnson with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $455.0B | 36.37% | 18.25 | 27.26% | |
| BUY | $351.4B | 6.48% | 21.92 | 19.74% | |
| HOLD | $140.1B | -31.89% | 13.04 | 16.84% |
The Johnson & Johnson stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Johnson & Johnson investment value today
Current value as on today
₹1,22,750
Returns
₹22,750
(+22.75%)
Returns from Johnson & Johnson Stock
₹17,049 (+17.05%)
Dollar Returns*
₹5,701 (+5.7%)
Based on 28 analysts
53.57%
Buy
46.43%
Hold
0.00%
Sell
Based on 28 analysts, 53.57% of analysts recommend a 'BUY' rating for Johnson & Johnson. Average target price of $199.56
Get share price movements and forecasts by analysts on Johnson & Johnson.
What analysts predicted
6.08%UPSIDE
Target Price
$199.56
Current Price
$187.43
Analyzed by
28 Analysts
Target
$199.56
Johnson & Johnson target price $199.56, a slight upside of 6.08% compared to current price of $187.43. According to 28 analysts rating.
Investment in Johnson & Johnson Shares on INDmoney has grown by 22.43% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:22.43% versus previous 30 day period
Search interest for Johnson & Johnson Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:42% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 November
Mon, 04:45 PM
-Johnson & Johnson may face legal challenges linked to Tylenol, despite spinning off Kenvue.
Mon, 06:27 PM
-Texas Attorney General files lawsuit against Kenvue, alleging Tylenol's link to autism, implicating J&J.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Johnson & Johnson has shown positive revenue growth over the last three quarters. The company's revenue increased from $21.89 billion to $23.99 billion, resulting in an average growth rate of 4.4% per quarter.
Price Rise
![]()
In the last 1 year, JNJ stock has moved up by 17.9%
Best in 1 Year
![]()
In the last 1 year, JNJ has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Procter & Gamble Company, The has given 13.9% return, outperforming this stock by 3.3%
Profit Down
![]()
Johnson & Johnson's net profit has been declining for the last three quarters, dropping from $10.99 billion to $5.15 billion. This represents an average decrease of 28.3% in profit each quarter.
| Organisation | Johnson & Johnson |
| Headquarters | One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933 |
| Industry | Health Technology |
| CEO | Mr. Joaquin Duato |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Dirk Brinckman | Chief Compliance Officer |
Mr. Joseph J. Wolk C.P.A. | Executive VP & CFO |
Mr. Timothy Schmid | Executive VP & Worldwide Chairman of MedTech |
Mr. Robert J. Decker Jr. | Controller & Chief Accounting Officer |
Mr. James Swanson | Executive VP & Chief Information Officer |
Mr. Darren Snellgrove | Vice President of Investor Relations |
Ms. Elizabeth Forminard J.D. | Executive VP & Chief Legal Officer |
Mr. Joaquin Duato | CEO & Chairman |
Ms. Jennifer L. Taubert | Executive VP & Worldwide Chairman of Innovative Medicine |
Dr. John C. Reed M.D., Ph.D. | Executive Vice President of Innovative Medicine, R&D |
Johnson & Johnson share price today is $187.43 as on . Johnson & Johnson share today touched a day high of $189.02 and a low of $186.64.
Johnson & Johnson share touched a 52 week high of $194.48 on and a 52 week low of $140.68 on . Johnson & Johnson stock price today i.e. is trending at $187.43,which is 3.63% down from its 52 week high and 33.23% up from its 52 week low.
Johnson & Johnson market capitalisation is $0.46T as on .
Indian investors can start investing in Johnson & Johnson (JNJ) shares with as little as ₹88.715 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.15 in Johnson & Johnson stock (as per the Rupee-Dollar exchange rate as on ).
Based on Johnson & Johnson share’s latest price of $187.43 as on November 3, 2025 at 11:42 pm IST, you will get 0.0534 shares of Johnson & Johnson. Learn more about
fractional shares .
Johnson & Johnson stock has given 36.37% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?